Enhanc3D Genomics appoints Hazel Jones as Chief Executive Officer

FHS
May 15, 2024
9:10 am

Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D genome for use in novel target identification and unique patient stratification, today announced the appointment of Hazel Jones as Chief Executive Officer, after a successful six-month tenure as interim CEO and COO.

The Rise of AI in Telemedicine: Enhancing Efficiency & Accessibility

Chu Canh Chieu, Director of Global Healthcare Center, FPT Software One of the silver linings of the COVID-19 pandemic was the rise of telemedicine. The

October 23, 2024

Ipsen’s Onivyde regimen gains FDA approval for pancreatic cancer

Share this article Ipsen’s Onivyde regimen is indicated as a first-line treatment for metastatic pancreatic adenocarcinoma. Credit: MattL_Images / Shutterstock.com. The US Food and Drug

February 14, 2024

Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate | Psychedelic Invest

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety,

June 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.